The European Journal of Health Economics

, Volume 16, Issue 4, pp 347–356 | Cite as

Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life

  • Jacinto Mosquera Nogueira
  • Eva Rodríguez-Míguez
Original Paper

Abstract

Alcohol dependence not only reduces life expectancy, but also causes considerable loss of quality of life of the dependents of and persons around those with alcohol dependence. This article presents new evidence on the impact of alcohol dependence on health-related quality of life in Spain. Three samples were recruited: 150 alcoholics and 64 family members of alcoholics, with both samples taken from an alcoholism treatment unit, and 600 persons from the general population. We used the short form 6D, a preference-based generic instrument, applying the utility scores estimated for Spain. It was found that the annual mean loss of quality-adjusted life years associated with alcohol dependence was 0.144 and 0.083 for the alcoholics and their close family members, respectively. This impact becomes more notable after controlling for socio economic variables and was higher than that estimated in similar studies. Possible explanations for these differences are discussed. The results from this work can be applied to economic evaluation studies measuring benefits from policies targeted at reducing the prevalence of alcohol dependence.

Keywords

Alcohol dependence SF-6D Quality-adjusted life year Spain 

JEL Classification

I1 

Notes

Acknowledgments

Financial support from the Consellería de Economía e Industria (Xunta de Galicia) grant no. 10SEC300038PR and from the Spanish Ministry of Science and Innovation grant no. ECO2011-25661 is gratefully acknowledged. We are also very grateful to professionals and patients from Alcoholism Care Unit of Vigo for their collaboration in this study.  

References

  1. 1.
    World Health Organization. The world health report 2002. www.who.int/whr/2002/es. Accessed 1 Nov 2013
  2. 2.
    World Health Organization: The global burden of disease. Update 2004. http://www.who.int/healthinfo/globalburden_disease/GBDreport_2004updatefull.pdf. Accessed 1 Nov 2013
  3. 3.
    Campos, J., Roca, L., Gude, F., González-Quintela, A.: Long-term mortality of patients admitted to the hospital with alcohol withdrawal syndrome. Alcohol Clin Exp Res 35, 1180–1186 (2011)CrossRefPubMedGoogle Scholar
  4. 4.
    John, U., Rumpf, H.J., Bischof, G., Hapke, U., Hanke, M., Meyer, C.: Excess mortality of alcohol-dependent individuals after 14 years and mortality predictors based on treatment participation and severity of alcohol dependence. Alcohol Clin Exp Res 37(1), 156–163 (2013)CrossRefPubMedGoogle Scholar
  5. 5.
    Markkula, N., Harkanen, T., Perala, J., Partti, K., Pena, S., Koskinen, S., Lonnqvist, J., Suvisaari, J., Saarni, S.I.: Mortality in people with depressive, anxiety and alcohol use disorders in Finland. Br J Psychiatry 200, 143–149 (2012)CrossRefPubMedGoogle Scholar
  6. 6.
    Vaillant, G.E.: A 60-year follow-up of alcoholic men. Addiction 98, 1043–1051 (2003)CrossRefPubMedGoogle Scholar
  7. 7.
    Daeppen, J.B., Krieg, M.A., Burnand, B., Yersin, B.: MOS-SF-36 in evaluating health-related quality of life in alcohol-dependent patients. Am J Drug Alcohol Abuse 24(4), 685–694 (1998)CrossRefPubMedGoogle Scholar
  8. 8.
    Kraemer, K., Maisto, S., Conigliaro, J., NcNeil, M., Gordon, A., Kelley, M.: Decreased alcohol consumption in outpatient drinkers is associated with improved quality of life and fewer alcohol-related consequences. J Gen Intern Med 17, 382–386 (2002)CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Lahmek, P., Berlin, I., Michel, L., Berghout, C., Meunier, N., Aubin, H.J.: Determinants of improvement in quality of life of alcohol-dependent patients during an inpatient withdrawal programme. Int J Med Sci 6(4), 160–167 (2009)CrossRefPubMedCentralPubMedGoogle Scholar
  10. 10.
    Pettinati, H., Gastfriend, D., Dong, Q., Kranzler, H., O’Malley, S.: Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients. Alcohol Clin Exp Res 33(2), 350–356 (2009)CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Strangesc, S., Notaro, J., Freudenheim, J.L., Calogero, R.M., Muti, P., Farinaro, E., Russell, M., Nochajski, T.H., Trevisan, M.: Alcohol drinking pattern and subjective health in a population-based study. Addiction 101(9), 1265–1276 (2006)CrossRefGoogle Scholar
  12. 12.
    Peltzer, K., Pengpid, S.: Alcohol use and health-related quality of life among hospital outpatients in South Africa. Alcohol Alcohol 47(3), 291–295 (2012)CrossRefPubMedGoogle Scholar
  13. 13.
    Malet, L., Llorca, P., Beringuier, B., Lehert, P., Falissard, B.: AlQol 9 for measuring quality of life in alcohol dependence. Alcohol Alcohol 41(2), 181–187 (2006)CrossRefPubMedGoogle Scholar
  14. 14.
    Drummond, M., Sculpher, M., Torrance, G., O’Brien, B., Stoddart, G.: Methods for the economic evaluation of health care programmes. Oxford University Press, New York (2005)Google Scholar
  15. 15.
    Taylor, R.S., Drummond, M., Salkeld, G., Sullivan, S.D.: Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. Br Med J 329(7472), 972–975 (2004)CrossRefGoogle Scholar
  16. 16.
    Moller, L., Matic, S. (World Health Organization Europe Regional Office): Best practice in estimating the costs of alcohol: Recommendations for future studies 2010. http://www.euro.who.int/__data/assets/pdf_file/0009/112896/E93197.pdf. Accessed 1 nov 2013
  17. 17.
    Popovici, I., French, M.T., McKay, J.R.: Economic evaluation of continuing care interventions in the treatment of substance abuse: recommendations for future research. Eval Rev 32, 547–568 (2008)CrossRefPubMedGoogle Scholar
  18. 18.
    Schori, M.: Valuation of drug abuse: a review of current methodologies and implications for policy making. Res Soc Work Pract 21(4), 421–431 (2011)CrossRefGoogle Scholar
  19. 19.
    Mathers, C., Ayuso-Mateos, J.L.: Global burden of alcohol use disorders in the year 2000. http://www.who.int/healthinfo/statistics/bod_alcohol.pdf. Accesed 1 nov 2013
  20. 20.
    Rawlins, M.D., Culyer, A.J.: National Institute for Clinical Excellence and its value judgments. Br Med J 329, 224–227 (2004)CrossRefGoogle Scholar
  21. 21.
    Kraemer, K., Roberts, M., Horton, N., Palfai, T., Samet, J., Freedner, N., Tibbetts, N., Saitz, R.: Health utility ratings for a spectrum of alcohol-related health states. Med Care 43(6), 541–550 (2005)CrossRefPubMedGoogle Scholar
  22. 22.
    Sanderson, K., Andrews, G., Corry, J., Lapsley, H.: Using the effect size to model change in preference values from descriptive health status. Qual Life Res 13, 1255–1264 (2004)CrossRefPubMedGoogle Scholar
  23. 23.
    Stouthard, M.E., Essink-Bot, M.L., Bonsel, G.L., Barendregt, J.J., Kramers, P.G., Water, H.P., Gunning-Schepers, L.J., Maas, P.J.: Disability weights for diseases in the Netherlands. Erasmus University, Rotterdam (1997)Google Scholar
  24. 24.
    Pyne, J., Tripathi, S., French, M., McCollister, K., Rapp, R., Booth, B.: Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction 106(3), 507–515 (2011)CrossRefPubMedCentralPubMedGoogle Scholar
  25. 25.
    Walters, D., Connor, J., Feeney, G., Young, R.: The cost effectiveness of naltrexone added to cognitive–behavioral therapy in the treatment of alcohol dependence. J Addict Dis 28(2), 137–144 (2009)CrossRefPubMedGoogle Scholar
  26. 26.
    Parrott, S., Godfrey, C., Heather, N., Clark, J., Ryan, T.: Cost and outcome analysis of two alcohol detoxification services. Alcohol Alcohol 41, 84–91 (2006)CrossRefPubMedGoogle Scholar
  27. 27.
    UK Alcohol Treatment Trial Research Team: Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). Br Med J 331, 544–548 (2005)CrossRefGoogle Scholar
  28. 28.
    Saarni, S., Suvisaari, J., Sintonen, H., Pirkola, S., Koskinen, S., Aromaa, A., Lonnqvist, J.: Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry 190, 326–332 (2007)CrossRefPubMedGoogle Scholar
  29. 29.
    Maheswaran, H., Petrou, S., Rees, K., Stranges, S.: Estimating EQ-5D utility values for major health behavioural risk factors in England. J Epidemiol Community Health 67, 172–180 (2013)CrossRefPubMedGoogle Scholar
  30. 30.
    Petrie, D., Doran, C., Shakeshaft, A., Sanson-Fisher, R.: The relationship between alcohol consumption and self-reported health status using the EQ5D. Soc Sci Med 67, 1717–1726 (2008)CrossRefPubMedGoogle Scholar
  31. 31.
    Laslett, A.M., Catalano, P., Chikritzhs, Y., Dale, C., Doran, C., Ferris, J., Jainullabudeen, T., Livingston, M., Matthews, S., Mugavin, J., Room, R., Schlotterlein, M., Wilkinson, C.: The range and magnitude of alcohol’s harm to others. AER Centre for Alcohol Policy Research, Turning Point Alcohol and Drug Centre Health, Fitzroy (2010)Google Scholar
  32. 32.
    Nutt, D., King, L., Phillips, L.: Drugs harms in the UK: a multicriteria decision analysis. Lancet 376, 1558–1565 (2010)CrossRefPubMedGoogle Scholar
  33. 33.
    Jarl, J., Johansson, P., Eriksson, A., Eriksson, M., Gerdtham, U., Hemström, O., Hradilova, K., Lenke, L., Ramstedt, M., Room, R.: The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. Eur J Health Econ 9, 351–360 (2008)CrossRefPubMedGoogle Scholar
  34. 34.
    Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J Health Econ 21(2), 271–292 (2002)CrossRefPubMedGoogle Scholar
  35. 35.
    Brazier, J., Roberts, J.: The estimation of a preference-based measure of health from the SF-12. Med Care 42(9), 851–859 (2004)CrossRefPubMedGoogle Scholar
  36. 36.
    Ware, J.E., Snow, K.K., Kolinski, M., Gandeck, B.: SF-36 health survey manual and interpretation guide. N.Engl Med Cent, Boston (1993)Google Scholar
  37. 37.
    Bharmal, M., Thomas, J.: Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health 9(4), 262–271 (2006)CrossRefPubMedGoogle Scholar
  38. 38.
    Longworth, L., Bryan, S.: An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 12(12), 1061–1067 (2003)CrossRefPubMedGoogle Scholar
  39. 39.
    Tsuchiya, A., Brazier, J., Roberts, J.: Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ 25, 334–346 (2006)CrossRefPubMedGoogle Scholar
  40. 40.
    Abellán, J.M., Sánchez, F.I., Martínez, J.E., Méndez, I.: Lowering the “floor” of the SF-6D scoring algorithm using a lottery equivalent method. Health Econ 21(11), 1271–1285 (2012)CrossRefGoogle Scholar
  41. 41.
    McCord, M., de Neufville, R.: Lottery equivalents: reduction of the certainty effect problem in utility assessment. Manage Sci 32, 56–60 (1986)CrossRefGoogle Scholar
  42. 42.
    McBee, M.: Modeling Outcomes With Floor or Ceiling Effects: an Introduction to the Tobit Model. Gifted Child Q 54(4), 314–320 (2010)CrossRefGoogle Scholar
  43. 43.
    Walters, S.J., Brazier, J.: Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 14(6), 1523–1532 (2005)CrossRefPubMedGoogle Scholar
  44. 44.
    American Psychiatric Association: Diagnostic and statistical manual of mental disorders,  4th edn. Author, Washington, DC (2000)Google Scholar
  45. 45.
    Babor, T.F., Biddle-Higgins, J.C., Saunders, J.B., Monteiro, M.G.: AUDIT: The alcohol use disorder identification test: guidelines for use in primary health care. World Health Organization, Geneva (2001)Google Scholar
  46. 46.
    Wittchen, H.U., Lachner, G., Wunderlich, U., Pfister, H.: Test–retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33, 568–578 (1998)CrossRefPubMedGoogle Scholar
  47. 47.
    Fergusson, D., Boden, J.M., Horwood, L.J.: Tests of causal links between alcohol abuse or dependence and major depression. Arch Gen Psychiatry 66(3), 260–266 (2009)CrossRefPubMedGoogle Scholar
  48. 48.
    Mentzakis, E., Suhrcke, M., Roberts, B., Murphy, A., McKee, M.: Estimating the causal effect of alcohol consumption on well-being for a cross-section of 9 former Soviet Union countries. Soc Sci Med 89, 1–7 (2013)CrossRefPubMedGoogle Scholar
  49. 49.
    Rehm, J., Rehm, M., Shield, K., Gmel, G., Gual, A.: Alcohol consumption, alcohol dependence and related harms in Spain, and the effect of treatment-based interventions on alcohol dependence. Adicciones 25(1), 11–18 (2013)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Jacinto Mosquera Nogueira
    • 1
  • Eva Rodríguez-Míguez
    • 2
  1. 1.Galician Health ServiceCentro de Salud de BembriveVigoSpain
  2. 2.Department of Applied EconomicsUniversity of VigoVigoSpain

Personalised recommendations